Loading, please wait...
DECEMBER 2018 RESIDENT SEMINAR
Please join us for the next session in our Resident Seminar series on Thursday, December 13, 2018 at 1:00 PM. Presented by PGY1 and PGY2 residents from within the St. Louis area, this series will focus on current therapeutic topics in the practice of pharmacy. All sessions will be held in the classrooms in the Academic & Research Building (ARB) on the third floor.
SCHEDULE:
|
|
ARB 304
|
ARB 305
|
ARB 336
|
ARB 337
|
ARB 355
|
|---|---|---|---|---|---|
|
BLOCK 1
1:00 – 1:45 pm
|
Katie Helm, Pharm.D. Neurosyphilis as an Early Disease in HIV Patients
|
Daniel Elliott, Pharm.D.
Optimizing Acute Ischemic Stroke Patient Process Workflow Across a Multistate Health-System
|
Daniel Britt, Pharm.D.
CF Gene Modulator Therapy Post-Lung Transplant: A Potential Untapped Role?
|
Shelley Monroe, Pharm.D.
Updates to the treatment of MRSA bacteremia in pediatric patients
|
Danica Balbach, Pharm.D.
The Use of Direct Oral Anticoagulants in Patients with Chronic Kidney Disease
|
|
1:45 – 1:55 pm
|
Travel Time to accommodate movement between rooms
|
||||
|
BLOCK 2
1:55 – 2:40
|
Sophia Hyunh, Pharm.D.
Angiotensin II: A Novel Treatment for Distributive Shock
|
Austin Hoefling, Pharm.D.
Re-evaluating the Use of Prazosin for Treatment of PTSD-related Nightmares
|
Matthew Daniels, Pharm.D.
Use of Extended Release Tacrolimus in Liver Transplant
|
Devin Dinora, Pharm.D.
Macrolide Use in the Treatment of Pediatric Community Acquired Pneumonia
|
Kristine Reckenberg, Pharm.D.
Genetic Testing to Predict Warfarin Response
|
|
2:40 – 2:50 pm
|
Travel Time to accommodate movement between rooms
|
||||
|
BLOCK 3
2:50 – 3:35 pm
|
|
Sarah Lowry, Pharm.D.
Bisphosphonate Drug Holidays: A Benefits and Risks Balancing Act
|
Alexandra Lovell, Pharm.D.
Management of 5-FU Induced Coronary Vasospasm
|
Lindsay Harris, Pharm.D.
CAPitalizing on Corticosteroids in Community Acquired Pneumonia
|
Meredith Hampton, Pharm.D.
Antiplatelet Bridging to Coronary Artery Bypass Graft
|
** Up to 0.75 hours of CE credit are available for each activity, for a maximum possible 2.25 hours if participants attend activities in both time blocks.**
| DOWNLOAD A SCHEDULE » | DOWNLOAD EVALUATION TEMPLATE » | CE INSTRUCTIONS » | REQUEST PARKING » | MAP & DIRECTIONS » |
REGISTRATION & PARKING INFORMATION
This event has mutliple concurrent sessions. Now that the event is concluded, you may register for a specific event you attended and complete the evaluation before December 27. To register, click the green button below. You will be asked to log in. You will be registered for the whole day - please complete the evaluations for only those sessions that you attend. Unattended sessions will be removed from your account, based on sign-in records, within a week following Seminar.
Registration is free, but is required in advance. Due to limited space, only those participants who register before 12:00 PM on Tuesday, December 11, 2018 will be able to request parking access on campus.
To request parking, please first register for your desired sessions. Then, complete the parking questionnaire using the link above, or by clicking here », to complete your parking request. If you do not request parking on our campus, or if you do not submit your requst by the deadline, you will be re-directed upon arrival.
HANDOUTS
Paper copies of handouts will be provided in each room as well as electronically on this website. Copies of PowerPoint slides are not provided. To access the handouts electronically, participants should ensure they are logged in before accessing this event. Click the + symbol beside the session, which will expand the module. A clickable text link to download the handout as a PDF file will be present.
ATTENDANCE
All participants will be required to sign in on the paper sheets, located within each room. Paper sign-in sheets will be reconciled against electronic credit reporting on this website.
CPE CREDIT
Participants must claim all CPE credit electronically. Participants may claim no more than one 45-minute session for each time block. Additional instructions can be downloaded above or read below.
SPECIAL ACCOMMODATIONS
If you require special accommodations, please notify us in advance. Every effort will be made to make accommodations where necessary.
Date: Dec 13, 2018 01:00 PM - 03:40 PM
Location: Academic & Research Building
Fee
$0.00
CE Hours
10.50
Registration closes on Dec 27, 2018 12:00 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Requirements for CE Credit
In order to receive CPE Credit, participants are required to submit an evaluation for the session.
- Evaluations will be housed online at this web address for 14 days, after which time they will be closed.
- Immediately upon submission of the online evaluation, a report will be automatically generated and submitted to CPE Monitor using the NABP ePID and DOB stored in the participant's account profile.
- Participants should allow up to 48 hours for the credit to sync with their online NABP e-Profiles. Paper statements of credit are not provided.
- Only ONE session may be claimed per each time block - if multiple concurrent sessions are claimed, participants forfeit CE credit. All CE claims will be cross-checked against the sign-in sheets.
If you experience difficulty, please contact our office so that we may assist you. We are happy to help!
Participants are responsible for ensuring accuracy of credit reporting and receipt of credit. It is recommended that participants log on and reivew the information under "my account" prior to submitting the evaluation. NABP ePID and date of birth must be accurate for credit reporting to occur. Evaluations cannot be reopened after 14 days.
Participants are encouraged to check their NABP eProfiles for receipt of credit within one week of submitting their evaluation(s). If a participant notices an error in credit on their NABP e-profile, they are encouraged to contact our office as soon as possible. To best comply with ACPE's CE credit reporting policy, St. Louis College of Pharmacy is unable, for any reason, to award or correct CE credit if more than 60 days have passed from the event.
Pharmacy STUDENTS should NOT use this page to register. Students should only complete the parking survey (CLICK HERE ») when registering. Students, if you already have a STLCOP parking permit, there is no need to complete the survey.
| Requests for parking are now CLOSED. |
Registration closes on Dec 27, 2018
at 12:00 AM
Registration closes on Dec 27, 2018
at 12:00 AM
Registration Closed
Registration Closed
Objectives
- Identify risk factors for neurosyphilis in patients with HIV.
- Recognize signs and symptoms of each stage of syphilis.
- Choose appropriate treatment for neurosyphilis in an HIV infected patient.
Activity Number
0033-0000-18-112-L02-P
Date:
12/13/18
Time:
01:00 PM - 01:45 PM
CE Hours
0.75
Location
ARB 304
Registration Closed
Registration Closed
Registration Closed
Objectives
- Identify in-hospital medications that may be utilized for the treatment and management of acute ischemic stroke.
- Evaluate strategies utilized by pharmacy to improve the management of acute ischemic stroke.
Activity Number
0033-0000-18-113-L01-P
Date:
12/13/18
Time:
01:00 PM - 01:45 PM
CE Hours
0.75
Location
ARB 305
Registration Closed
Registration Closed
Registration Closed
Objectives
- Identify the cystic fibrosis (CF) mutations that are associated with cystic fibrosis transmembrane conductance regulator protein (CFTR) modulator use.
- Identify the advantages and disadvantages of using CFTR modulators pre- and post-lung transplant.
Activity Number
0033-0000-18-102-L01-P
Date:
12/13/18
Time:
01:00 PM - 01:45 PM
CE Hours
0.75
Location
ARB 336
Registration Closed
Registration Closed
Registration Closed
Objectives
- Describe the epidemiology, incidence, and outcomes of S. aureus bacteremia (SAB).
- Summarize the Infectious Disease Society of America (IDSA) guideline recommendations for the treatment of SAB and short-comings of first-line treatment.
- Describe literature supporting alternative treatment options in pediatric patients.
Activity Number
0033-0000-18-114-L01-P
Date:
12/13/18
Time:
01:00 PM - 01:45 PM
CE Hours
0.75
Location
ARB 337
Registration Closed
Registration Closed
Registration Closed
Objectives
- Identify risks associated with the use of direct oral anticoagulants in patients with chronic kidney disease.
- Interpret the results of the recent trials evaluating the use of direct oral anticoagulants in patients receiving dialysis.
- Select direct oral anticoagulants with supporting evidence for use in patients receiving intermediate hemodialysis.
Activity Number
0033-0000-18-101-L01-P
Date:
12/13/18
Time:
01:00 PM - 01:45 PM
CE Hours
0.75
Location
ARB 355
Registration Closed
Registration Closed
Registration Closed
Objectives
- Describe Angiotensin II’s mechanism of action.
- Recognize potential advantages and disadvantages of Angiotensin II use according to recent published trial results.
- Examine where Angiotensin II fits in current practice.
Activity Number
0033-0000-18-107-L01-P
Date:
12/13/18
Time:
01:55 PM - 02:40 PM
CE Hours
0.75
Location
ARB 304
Registration Closed
Registration Closed
Registration Closed
Objectives
- Describe the proposed mechanism of prazosin for reduction of PTSD-related nightmares.
- Identify patients who are most likely to benefit from the use of prazosin for PTSD-related nightmares.
Activity Number
0033-0000-18-106-L01-P
Date:
12/13/18
Time:
01:55 PM - 02:40 PM
CE Hours
0.75
Location
ARB 305
Registration Closed
Registration Closed
Registration Closed
Objectives
- Identify the different formulations of tacrolimus used in liver transplantation.
- Describe the differences in the pharmacokinetic profiles of the immediate release formulation and both extended release formulations of tacrolimus.
- Evaluate the potential role of LCPT in liver transplant patients.
Activity Number
0033-0000-18-103-L01-P
Date:
12/13/18
Time:
01:55 PM - 02:40 PM
CE Hours
0.75
Location
ARB 336
Registration Closed
Registration Closed
Registration Closed
Objectives
- Determine criteria for using Macrolide antibiotics in hospitalized pediatric patients with community acquired pneumonia, according to the current IDSA guideline recommendations.
- Make evidence based recommendations for or against the use of Macrolide antibiotics for the treatment of pediatric community acquired pneumonia.
Activity Number
0033-0000-18-104-L01-P
Date:
12/13/18
Time:
01:55 PM - 02:40 PM
CE Hours
0.75
Location
ARB 337
Registration Closed
Registration Closed
Registration Closed
Objectives
- List pharmacogenetic variables that impact warfarin dose requirements.
- Describe how pharmacogenetic variables impact warfarin dose requirements.
- Identify an appropriate warfarin initiation strategy for a patient undergoing elective hip or knee arthroplasty given the results of the GIFT trial.
Activity Number
0033-0000-18-110-L01-P
Date:
12/13/18
Time:
01:55 PM - 02:40 PM
CE Hours
0.75
Location
ARB 355
Registration Closed
Registration Closed
Registration Closed
Objectives
- Explain the benefits and risks of a bisphosphonate drug holiday.
- Describe bisphosphonates????impact on drug holidays based on primary literature, including alendronate, risedronate, and zoledronic acid.
- Identify patients at high risk for fracture that may benefit from longer bisphosphonate treatment.
Activity Number
0033-0000-18-109-L01-P
Date:
12/13/18
Time:
02:50 PM - 03:35 PM
CE Hours
0.75
Location
ARB 305
Registration Closed
Registration Closed
Registration Closed
Objectives
- Identify risk factors for the development of 5-fluorouracil (5-FU) induced coronary vasospasm.
- List signs and symptoms of 5-fluorouracil (5-FU) induced coronary vasospasm.
- Describe management strategies for treatment of 5-FU or capecitabine induced coronary vasospasm.
Activity Number
0033-0000-18-108-L01-P
Date:
12/13/18
Time:
02:50 PM - 03:35 PM
CE Hours
0.75
Location
ARB 336
Registration Closed
Registration Closed
Registration Closed
Objectives
- Identify the most common adverse effects of systemic corticosteroids.
- Compare and contrast studies evaluating the use of corticosteroids in community acquired pneumonia.
- Select a patient with community acquired pneumonia who would most likely benefit from adjunctive corticosteroid therapy.
Activity Number
0033-0000-18-105-L01-P
Date:
12/13/18
Time:
02:50 PM - 03:35 PM
CE Hours
0.75
Location
ARB 337
Registration Closed
Registration Closed
Registration Closed
Objectives
- Define the patient population who may be candidates for antiplatelet bridging therapy.
- Describe the available therapeutic options for bridging and their place in therapy.
- Determine the quality of existing evidence for antiplatelet bridging therapy.
Activity Number
0033-0000-18-111-L01-P
Date:
12/13/18
Time:
02:50 PM - 03:35 PM
CE Hours
0.75
Location
ARB 355
Registration Closed
